These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15302009)

  • 1. Clinical improvement with repeated courses of intravenous B-type natriuretic peptide in refractory heart failure.
    Spevack DM; Matros T; Shah A; Dweck E; Tunick PA
    Eur J Heart Fail; 2004 Aug; 6(5):611-3. PubMed ID: 15302009
    [No Abstract]   [Full Text] [Related]  

  • 2. Nesiritide speeds recovery time for heart failure patients.
    Morrow T
    Manag Care; 2004 Jul; 13(7):60-1. PubMed ID: 15347161
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of ultrafiltration on renal function in patients with decompensated heart failure.
    Kazory A; Ross EA
    Congest Heart Fail; 2009; 15(4):210-1. PubMed ID: 19627301
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimizing treatment of chronic decompensated heart failure in the outpatient setting.
    Silver MA
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S28-36. PubMed ID: 15627916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.
    Riter HG; Redfield MM; Burnett JC; Chen HH
    J Am Coll Cardiol; 2006 Jun; 47(11):2334-5. PubMed ID: 16750705
    [No Abstract]   [Full Text] [Related]  

  • 6. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
    Saltzberg MT
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nesiritide: the latest drug for treating heart failure.
    Fontana D
    Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809
    [No Abstract]   [Full Text] [Related]  

  • 8. B-type natriuretic peptides in management of acute decompensated heart failure.
    Yancy CW
    Heart Fail Clin; 2006 Jul; 2(3):353-64. PubMed ID: 17386904
    [No Abstract]   [Full Text] [Related]  

  • 9. Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.
    Munger MA; Ng TM; Van Tassell BW
    Pharmacotherapy; 2007 May; 27(5):619-25. PubMed ID: 17461695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal protection with recombinant b-type natriuretic peptide in a burn patient with rhabdomyolysis.
    Hutchens MP; Weinmann M
    Burns; 2006 Feb; 32(1):128-31. PubMed ID: 16384649
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
    Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial).
    Yancy CW; Singh A
    Am J Cardiol; 2006 Jul; 98(2):226-9. PubMed ID: 16828598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
    Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
    J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nesiritide: a unique therapeutic cardiac peptide.
    Rayburn BK; Bourge RC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S25-31. PubMed ID: 12439359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic conjugates of human brain natriuretic peptide designed for oral delivery: in vitro activity screening.
    Miller MA; Malkar NB; Severynse-Stevens D; Yarbrough KG; Bednarcik MJ; Dugdell RE; Puskas ME; Krishnan R; James KD
    Bioconjug Chem; 2006; 17(2):267-74. PubMed ID: 16536455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide: a diagnostic and treatment hormone for perioperative congestive heart failure.
    Skidmore KL; Russell IA
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):780-7. PubMed ID: 15650995
    [No Abstract]   [Full Text] [Related]  

  • 17. Nesiritide for acute decompensated heart failure.
    Alhosaini H
    Am Fam Physician; 2006 Oct; 74(8):1279; author reply 1279-80. PubMed ID: 17087421
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure.
    McCullough PA; Kuncheria J; Mathur VS
    Rev Cardiovasc Med; 2003; 4 Suppl 7():S3-S12. PubMed ID: 14668695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction: optimizing heart failure management.
    Heywood JT
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S1-2. PubMed ID: 15627914
    [No Abstract]   [Full Text] [Related]  

  • 20. Nesiritide for the treatment of decompensated heart failure.
    Wylie JV; Tsao L
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.